1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > In Vitro Diagnostics

In-Vitro Testing Equipment Industry: Comprehensive Market Analysis

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
22 votes

More market segments:

In Vitro Diagnostics

The process of testing and analyzing human samples, such as blood or tissue to diagnose infections and health conditions is called in vitro diagnostics (IVDs). The purpose of IVD tests is to assess the health status of a patient. These tests are performed outside of the body. Checking blood for signs of infections, tests for infectious disease, such as HIV or hepatitis, cholesterol, anaemia and for various genetic diseases or conditions are common uses of IVDs.

Federal agencies involved in the regulation of IVDs in the USA include the Food and Drug Administration and the Centers for Medicare & Medicaid Services. Roche Diagnostics Limited, Abbott Laboratories, Inc. and Siemens Healthcare are some of the major players in the in vitro market.

Key Market Segments

IVDs of the types mentioned below are used in health care in numerous ways and at various points.

Clinical laboratory testing: These tests are generally prescribed by the physician. The information obtained assists in the evaluation of overall health, in disease diagnosis and in the establishment of appropriate treatment. Clinical laboratory tests influence approximately 70% of healthcare decisions.

Point-of-care diagnostics: This kind of test is carried out by healthcare professionals, such as doctors, nurses or paramedics. These tests do not require specialist laboratory facilities and can normally deliver results very quickly. This type of testing is used for providing insights for a preliminary diagnosis or for managing patient conditions.

Self-testing: These tests are designed for patients or individuals to use themselves. They do not require any specialist facilities, and the user can usually interpret the information. The most familiar are bloodsugar tests for managing diabetes and home pregnancy tests, but a variety of other tests is becoming widely available. HIV self-testing is increasingly being sought and offered globally.

Regional Market Shares

Increasing emphasis on the early detection of diseases and infections is likely to drive the global demand for IVDs to about $75 billion by 2020. The USA, Europe and Asia account for the largest share of the IVD market.

The USA is one of the largest markets for IVDs in the world, with a market value of more than $24 billion. Professional point-of-care diagnostics is the largest segment in the USA. Population aging and expansion of the insured population resulting from the Affordable Care Act are likely to drive growth of the US IVD market to more than $28 billion in the near future.

The healthcare system in most of Europe depends on government funding. As a result the IVD market in Europe has recently witnessed slow growth as governments have cut costs. Increasing incidence of serious diseases has, however, driven up the market; the European market for cancer IVD, for instance, was worth more than $1.5 billion in 2015.

Asia’s IVD market is estimated to be worth more than $17 billion. Corporate firms offering annual health checks for their employees and insurance companies conducting pre-insurance policy checks are fuelling the industry. Increasing levels of chronic diseases, patient awareness, patient self testing and significant urban populations are driving the uptake of various IVD tests and creating opportunities for market expansion.

Read more »

Customer Support

Talk to Sam

+1 646 893 5945

28 Reports
Company, Market Size, Company Financials
7 Statistics
Market Size, Finance, Company Financials
110 Reports
Company, Demand, Company Financials
1 Statistics
Market Size, Finance, Company Financials
7 Reports
Market Size, Company, Company Financials
1 Statistics
Market Size, Demand, Finance
4 Reports
Demand, Company Financials, Market Size
8 Reports
Market Size, Company, Company Financials
6 Reports
Demand, Supply, Forecast
4 Reports
Demand, Company Financials, Market Size
1 Statistics
Market Size, Demand, Finance
Search in In Vitro Diagnostics Industry (About 300 reports)
Parent industry: Diagnostics

About 4000 reports

Purchase Reports From Reputable Market Research Publishers

A 33-Country Survey of the Automated Microbiology Market 2017-2022: Supplier Country Shares, Sales&Volume Forecast for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening&Immunodiagnostic Test

A 33-Country Survey of the Automated Microbiology Market 2017-2022: Supplier Country Shares, Sales&Volume Forecast for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening&Immunodiagnostic Test

  • $ 47500
  • Industry report
  • January 2018

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2018 World Coagulation Testing Analyzers and Reagents M ... $ 33500 March 2018

World Coagulation Testing Market 2017-2022: Supplier Co ... $ 33500 January 2018

A 33-Country Survey of the Coagulation Testing Market 2 ... $ 28500 January 2018

2018 Competing in the Global Clinical Chemistry and Imm ... $ 21800 April 2018

2019-2023 Global Hemostasis Diagnostic Analyzers and Re ... $ 21100 January 2019

2018 Global Hemostasis Diagnostics Market Shares, Segme ... $ 21100 September 2018

2018 Global Coagulation Market: US, Europe, Japan--Supp ... $ 21100 July 2018

2018 Global Coagulation Market Future Horizons and Grow ... $ 21100 June 2018

2018 Hemostasis Analyzers and Reagents Market: Supplier ... $ 21100 June 2018


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on